Natalie Matosin

Q: What Schools Are Affiliated With Natalie Matosin

Natalie Matosin is affiliated with the following schools: University of New South Wales, University of Wollongong

Natalie Matosin's AcademicInfluence.com Rankings

Natalie Matosin

Psychology

#4409

World Rank

#4912

Historical Rank

psychology Degrees

Natalie Matosin

Biology

#9057

World Rank

#12214

Historical Rank

biology Degrees

Download Badge

Psychology
Biology

Why Is Natalie Matosin Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Dr. Natalie Matosin is an Australian scientist known for research into the human brain in health and disease, and particularly how stress raises risk to mental illness. Matosin's research has been published in prestigious academic journals, as well as on The Conversation. Matosin spoke at TEDx Hamburg in June 2017 and is the 2021 Al & Val Rosenstrauss Fellow. She was previously a National Health and Medical Research Council CJ Martin Early Career Research Fellow, and Alexander von Humboldt Fellow. In 2017, Matosin was listed as a Forbes 30 Under 30 in Europe in the category of Science & Healthcare, placing her in the top 1% of innovators worldwide.

(See a Problem?)

Natalie Matosin's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Negativity towards negative results: a discussion of the disconnect between scientific worth and scientific culture (2014) (180)
Understanding the Molecular Mechanisms Underpinning Gene by Environment Interactions in Psychiatric Disorders: The FKBP5 Model (2018) (135)
Metabotropic glutamate receptor 5 in the pathology and treatment of schizophrenia (2013) (78)
Molecular evidence of synaptic pathology in the CA1 region in schizophrenia (2016) (59)
Metabotropic glutamate receptor mGluR2/3 and mGluR5 binding in the anterior cingulate cortex in psychotic and nonpsychotic depression, bipolar disorder and schizophrenia: implications for novel mGluR-based therapeutics. (2014) (57)
Homer1/mGluR5 Activity Moderates Vulnerability to Chronic Social Stress (2015) (56)
Preclinical and Clinical Evidence of DNA Methylation Changes in Response to Trauma and Chronic Stress (2017) (52)
Alterations of mGluR5 and its endogenous regulators Norbin, Tamalin and Preso1 in schizophrenia: towards a model of mGluR5 dysregulation (2015) (42)
Metabotropic glutamate receptor 5 binding and protein expression in schizophrenia and following antipsychotic drug treatment (2013) (38)
Shifting towards a model of mGluR5 dysregulation in schizophrenia: Consequences for future schizophrenia treatment (2017) (38)
Rethinking metabotropic glutamate receptor 5 pathological findings in psychiatric disorders: implications for the future of novel therapeutics (2014) (28)
Metabotropic glutamate receptor 5, and its trafficking molecules Norbin and Tamalin, are increased in the CA1 hippocampal region of subjects with schizophrenia (2015) (26)
How stress physically re-shapes the brain: Impact on brain cell shapes, numbers and connections in psychiatric disorders (2019) (22)
Neuronal hyperexcitability in Alzheimer’s disease: what are the drivers behind this aberrant phenotype? (2022) (21)
Interactions of early-life stress with the genome and epigenome: from prenatal stress to psychiatric disorders (2017) (19)
Neurodevelopmental Expression Profile of Dimeric and Monomeric Group 1 mGluRs: Relevance to Schizophrenia Pathogenesis and Treatment (2016) (19)
Effects of common GRM5 genetic variants on cognition, hippocampal volume and mGluR5 protein levels in schizophrenia (2018) (18)
Alterations of ubiquitin related proteins in the pathology and development of schizophrenia: Evidence from human and animal studies. (2017) (12)
Severe childhood and adulthood stress associates with neocortical layer-specific reductions of mature spines in psychiatric disorders (2020) (10)
The Role of Cathepsins in Memory Functions and the Pathophysiology of Psychiatric Disorders (2020) (9)
Possibility of a sex-specific role for a genetic variant in FRMPD4 in schizophrenia, but not cognitive function (2016) (7)
mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia (2016) (7)
Common variation in ZNF804A (rs1344706) is not associated with brain morphometry in schizophrenia or healthy participants (2017) (6)
Alterations of p75 neurotrophin receptor and Myelin transcription factor 1 in the hippocampus of perinatal phencyclidine treated rats (2015) (5)
NMDA receptor antagonism by phencyclidine reduces NWASP and WAVE1 protein expression and reduces levels of myelination markers in the prefrontal cortex of rats (2015) (4)
Stress-Related Memory Impairments Are Modulated by the Synergistic Action of Stress Hormones: Implications for PTSD (2017) (4)
Metabotropic Glutamate Receptor 5 as a Point of Convergence for Models of Obsessive-Compulsive Disorder and Autism Spectrum Disorder (2016) (3)
Perinatal administration of phencyclidine alters expression of Lingo-1 signaling pathway proteins in the prefrontal cortex of juvenile and adult rats (2018) (3)
PM491. The Neurodevelopmental Profile of Group 1 Metabotropic Glutamate Receptors: Implications for Novel Therapeutics (2016) (3)
Chronic Adolescent CDPPB Treatment Alters Short-Term, but not Long-Term, Glutamatergic Receptor Expression (2018) (2)
Positives in negative results: when finding 'nothing' means something (2014) (2)
Brain expressed FKBP5 delineates a therapeutic subtype of severe mental illness (2021) (2)
Poster #S173 METABOTROPIC GLUTAMATE RECEPTOR 5 DYSREGULATION IN SCHIZOPHRENIA (2014) (2)
Exploring mGluR5 dysregulation in schizophrenia: from gene to protein (2015) (1)
Alterations in Astrocytic Regulation of Excitation and Inhibition by Stress Exposure and in Severe Psychopathology (2022) (1)
Associations of psychiatric disease and ageing with FKBP5 expression converge on superficial layer neurons of the neocortex (2023) (1)
Understanding the pathology of psychiatric disorders in refugees (2020) (1)
Novel implications of Lingo-1 signaling in the prefrontal cortex of perinatal phencyclidine treated rats in a neurodevelopmental model of schizophrenia (2017) (0)
Erratum to: mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia (2016) (0)
Alterations of mGluR5 and mGluR5 signaling partners in schizophrenia (2014) (0)
Associations of psychiatric disease and aging on FKBP5 expression converge on cortical supragranular neurons (2022) (0)
single-cell-type levels in severe psychiatric disorders (2021) (0)
mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia (2016) (0)
An analysis of metabotropic glutamate receptors 2/3 and 5 in schizophrenia, major depression and bipolar disorder from the stanley neuropathology consortium (2013) (0)
Metabotropic glutamate receptor in the pathophysiology and treatment of schizophrenia and major depression (2014) (0)
' s response to reviews Title : Metabotropic glutamate receptor 5 : a candidate in psychiatric pathology ? Implications for novel mGluR 5-based therapeutics (2014) (0)
69. The Postmortem Human Brain to Characterize Novel Drug Targets for Psychiatric Disorders: Using FKBP5 as an Example (2018) (0)
Effects of GRASP variation on memory in psychiatrically healthy individuals and cognitive dysfunction in schizophrenics (2017) (0)
MGluR5 and NMDA receptor density are reduced in the dorsolateral prefrontal cortex of schizoaffective but not schizophrenia patients (2012) (0)
Erratum to: mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia (2016) (0)
Variant-risk-exon interplay impacts on cortical cell-cell interactions in severe psychiatric disorders (2022) (0)
Explication of FKBP5 Methylation and Transcription Patterns in Postmortem Human Cortex (2017) (0)
Effects of common GRM5 genetic variants on cognition, hippocampal volume and mGluR5 protein levels in schizophrenia (2017) (0)
VARIANT-RISK-EXON INTERPLAY IMPACTS ON CELL-CELL INTERACTIONS IN THE HUMAN CORTEX IN SEVERE PSYCHIATRIC DISORDERS (2022) (0)
Chronic Adolescent CDPPB Treatment Alters Short-Term, but not Long-Term, Glutamatergic Receptor Expression (2018) (0)
Subchronic metabotropic glutamate 5 receptor modulation in the perinatal pcp rodent model of schizophrenia (2013) (0)
Spatial transcriptomic analysis of adult hippocampal neurogenesis in the human brain (2023) (0)

This paper list is powered by the following services:

Other Resources About Natalie Matosin

en.wikipedia.org

What Schools Are Affiliated With Natalie Matosin?

Natalie Matosin is affiliated with the following schools:

Natalie Matosin's Academic­Influence.com Rankings

Why Is Natalie Matosin Influential?

Natalie Matosin's Published Works

Published Works

Other Resources About Natalie Matosin

What Schools Are Affiliated With Natalie Matosin?

Natalie Matosin's AcademicInfluence.com Rankings